What should reporters know about ketamine safety?
Ketamine is a legitimate medication used in anesthesia and other clinical settings, but its risks depend on the patient, dose, purpose, and level of supervision. Reporting should distinguish appropriately monitored clinical use from unmonitored or recreational use and examine the safeguards available if complications occur.
Ketamine is a legitimate dissociative anesthetic with important medical uses, but it can also cause sedation, dissociation, amnesia, impaired judgment, unconsciousness, and respiratory depression. Reporting should distinguish supervised medical use from unmonitored or recreational exposure while recognizing that the drug’s pharmacology does not disappear outside an operating room.
Two separate policy questions
Medical administration: patient selection, known dose, monitoring, rescue capability, staffing, recovery, adverse-event reporting, and medical accountability.
Recreational or unmonitored use: uncertain dose or contents, impaired judgment and consent, accidental injury, vulnerability to assault, unconsciousness, and potentially dangerous respiratory effects.
Full TSA resources: Medical ketamine safety standards • Recreational and unmonitored ketamine risks
Federal source: DEA — Ketamine Fact Sheet ↗
Sources
- DEA — Ketamine Drug Fact Sheet
- FDA — Compounding risk alerts, including ketamine
- TSA — Safety standards for clinical ketamine therapy
- TSA — Risks of recreational and unmonitored ketamine use
Reviewed By
- Physician reviewer:
- Russell McAllister, MD, FASA Verify certification and MOCA status (opens in a new tab)
- Board certification:
- Anesthesiology — American Board of Anesthesiology (ABA)
- Additional reviewer:
- Jeremie J. Perry, MD, FASA
- Last reviewed: